The Insight Partners published latest research report on “Organoids Market Trends Report, Size, Growth, Value, Scope, Share Forecasts to 2027 - COVID-19 Impact and Global Analysis By Type; Application; Source, and Geography,”
The Insight Partners published latest research report on “Organoids Market Trends Report, Size, Growth, Value, Scope, Share Forecasts to 2027 - COVID-19 Impact and Global Analysis By Type; Application; Source, and Geography,” the global market size was valued at USD 689.47 million in 2019 and is expected to reach USD 3,420.40 million by 2027, it is expected to grow at a CAGR of 22.1% from 2020 to 2027.
Download PDF Brochure: https://www.theinsightpartners.com/sample/TIPRE00017616
Global Organoids Market Growth Drivers:
• Advancements in Stem Cell Research: Stem cell research has led to the development of organoids, which are 3D structures that mimic the structure and function of human organs. As advancements in stem cell research continue, the potential applications of organoids are expected to expand, driving growth in the market.
• Growing Demand for Personalized Medicine: Organoids have the potential to be used in personalized medicine, where treatments are tailored to an individual’s specific needs. As the demand for personalized medicine grows, the demand for organoids is also expected to increase.
• Rising Prevalence of Chronic Diseases: Chronic diseases such as cancer, diabetes, and neurological disorders are becoming more prevalent, and there is a growing need for better models to study these diseases. Organoids offer a more accurate representation of human tissue than traditional 2D cell cultures, making them a valuable tool for disease modeling and drug discovery.
• Increasing Investment: The organoids market has attracted significant investment from venture capitalists, pharmaceutical companies, and other investors, which is expected to drive innovation and growth in the industry.
• Technological Advancements: Advances in imaging, microfabrication, and bioengineering are making it easier to create and study organoids. These technological advancements are expected to continue to drive growth in the organoids market.
Global Organoids Market Insights: Recent Developments:
• Expansion of Organoid Applications: Organoids have been used in disease modeling, drug discovery, and personalized medicine, and researchers are discovering new applications for organoids, such as studying the effects of environmental toxins and infectious diseases.
• Growing Use of CRISPR Technology: CRISPR-Cas9 technology has enabled researchers to edit genes in organoids, creating new models for disease research and drug discovery.
• Increased Collaboration: Collaboration between academic and industry researchers has accelerated the development and commercialization of organoid technologies. For example, pharmaceutical companies are partnering with academic institutions to use organoids to screen drug candidates more efficiently.
• Development of Multi-Organoid Systems: Multi-organoid systems are being developed, which enable researchers to study interactions between different organs and to model diseases that affect multiple organs.
• Advances in Imaging and Analysis: Advances in imaging and analysis techniques, such as single-cell RNA sequencing, are providing new insights into the biology of organoids and enabling researchers to study cellular interactions in more detail.
Quickly Purchase Premium Copy of Organoids Market Growth Report (2020-2027) at: https://www.theinsightpartners.com/buy/TIPRE00017616
Global Organoids Market Report Scope, Segmentations, Regional & Country Scope:
| Report Coverage | Details |
| Market Size Value in | USD 689.47 Million in 2019 |
| Market Size Value by | USD 3,420.40 Million by 2027 |
| Growth rate | CAGR of 22.1% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
| No. of Pages | 174 |
| No. of Tables | 84 |
| No. of Charts & Figures | 77 |
| Historical data available | Yes |
| Segments covered | Type; Application; Source; and Geography |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Country scope | US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Companies Covered | STEMCELL Technologies, Cellesce Ltd., Hubrecht Organoid Technology, Definigen, 3Dnamics, Inc., Organoid Therapeutics, PeproTech, Inc., Thermo Fisher Scientific, Corning Incorporated (Life Sciences), Merck KGgA |
| Key Research Capabilities | Global Market Assessment, Business Development Strategies, Competitive Landscape, Opportunity Analysis, Regional and Country Level Market Analysis, Market Entry Strategies, Market Dynamics, Risk and Return Assessments, Pricing Analysis, Market Size and Forecasting, Company Profiling, Value Chain Analysis, Expansion Strategies, SWOT Analysis, New Product Development |
Browse key market insights spread across 174 pages with 84 list of tables & 77 list of figures from the report, “Organoids Market Share Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Stomach, Intestine, Liver, Pancreas, Lung, Brain, Kidney, Others); Application (Developmental Biology, Disease Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity and Efficacy Testing, Drug Discovery and Personalized Medicine, Others); Source (Pluripotent Stem Cells, Organ-specific Adult Stem Cells), and Geography” in detail along with the table of contents: https://www.theinsightpartners.com/reports/organoids-market
STEMCELL Technologies, Cellesce Ltd., Hubrecht Organoid Technology, Definigen, 3Dnamics, Inc., Organoid Therapeutics, PeproTech, Inc., Thermo Fisher Scientific, Corning Incorporated (Life Sciences), Merck KGgA are a few of the key players profiled during the study of the global organoids market. Several other major companies were also analyzed to get a holistic view of the market and its ecosystem.
Animal models are widely used in biomedical research for human-specific diseases. However, various cases demonstrate that animal models cannot always be predictive for human drug response, for instance, drug toxicology studies. This is because there are wide variations in the metabolism of drugs and toxins in humans compared to animals, which makes it nearly impossible to study drug metabolism in experimental models, such as laboratory rodent species. Additionally, in recent years, several regulations have been implemented that restrict animal use in research activities. Similarly, several bodies, such as Cruelty-Free International and the Fund for the Replacement of Animals in Medical Experiments, oppose animal-based models for research purposes.
Therefore, in order to develop alternative testing models that can provide an environment with full equivalence to the human body, various institutes are involved in developing alternative methods for drug development and biomedical research. As organoids can serve as alternatives to animal models, the current focus on reducing animal use in research is expected to support the growth of the human organoids market.
North America dominated the Organoids market with ~42% market share in 2021. The market growth in the region is majorly attributed to increasing R&D expenditure and government funding, well-developed healthcare infrastructure, high cancer prevalence, continuously flourishing pharmaceutical and life sciences sector, and strategic initiatives by prominent players in the region. Further, the COVID-19 pandemic offered a massive boost to the pharmaceutical industry in the region, as the US FDA authorized many medications in the last two years (including emergency use authorizations).
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/organoids-market